Dual JAK2/Aurora kinase A inhibition prevents human skin graft rejection by allo-inactivation and ILC2-mediated tissue repair.

Saved in:
Bibliographic Details
Title: Dual JAK2/Aurora kinase A inhibition prevents human skin graft rejection by allo-inactivation and ILC2-mediated tissue repair.
Authors: Walton K; Division of Hematology, Oncology, and Transplantation, Department of Medicine, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Walker K; Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Riddle M; Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Koehn BH; Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Reff J; Department of Immunology, Moffitt Cancer Center, Tampa, Florida., Sagatys EM; Department of Immunology, Moffitt Cancer Center, Tampa, Florida.; Department of Hematopathology and Laboratory Medicine, Moffitt Cancer Center, Tampa, Florida., Linden MA; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota., Pidala J; Department of Immunology, Moffitt Cancer Center, Tampa, Florida.; Department of Oncologic Sciences, Moffitt Cancer Center, Tampa, Florida.; Department of Blood and Marrow Transplantation - Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida., Kim J; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida., Lee MC; Department of Oncologic Sciences, Moffitt Cancer Center, Tampa, Florida.; Department of Breast Oncology, Moffitt Cancer Center, Tampa, Florida., Kiluk JV; Department of Oncologic Sciences, Moffitt Cancer Center, Tampa, Florida.; Department of Breast Oncology, Moffitt Cancer Center, Tampa, Florida., Hui JYC; Department of Surgery, University of Minnesota, Minneapolis, Minnesota., Yun SY; Department of Oncologic Sciences, Moffitt Cancer Center, Tampa, Florida.; Department of Drug Discovery, Moffitt Cancer Center, Tampa, Florida., Xing Y; Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Stefanski H; Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Lawrence HR; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota.; Department of Drug Discovery, Moffitt Cancer Center, Tampa, Florida., Lawrence NJ; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota.; Department of Drug Discovery, Moffitt Cancer Center, Tampa, Florida., Tolar J; Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Anasetti C; Department of Immunology, Moffitt Cancer Center, Tampa, Florida.; Department of Oncologic Sciences, Moffitt Cancer Center, Tampa, Florida.; Department of Blood and Marrow Transplantation - Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida., Blazar BR; Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Sebti SM; Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia., Betts BC; Division of Hematology, Oncology, and Transplantation, Department of Medicine, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
Source: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2022 Mar; Vol. 22 (3), pp. 717-730. Date of Electronic Publication: 2021 Nov 08.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100968638 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-6143 (Electronic) Linking ISSN: 16006135 NLM ISO Abbreviation: Am J Transplant Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1600-6143
DOI:10.1111/ajt.16870